Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Study illuminates how BRD4 protein directs the spatial organization of DNA within cell nucleus

Study illuminates how BRD4 protein directs the spatial organization of DNA within cell nucleus

Hollings Cancer Center researcher awarded NCI grant to pursue early investigator studies in leukemia

Hollings Cancer Center researcher awarded NCI grant to pursue early investigator studies in leukemia

CAR-T cells require an abundance of antigens to efficiently kill solid tumors

CAR-T cells require an abundance of antigens to efficiently kill solid tumors

Humoral responses to SARS-CoV-2 are detectable through saliva, scientists find

Humoral responses to SARS-CoV-2 are detectable through saliva, scientists find

Antiviral activity of wheat germ Agglutinin against SARS-CoV-2

Antiviral activity of wheat germ Agglutinin against SARS-CoV-2

Study reveals how the blood and immune systems develop in prenatal bone marrow

Study reveals how the blood and immune systems develop in prenatal bone marrow

Novel small-molecule therapy shows promise against deadly pediatric leukemia

Novel small-molecule therapy shows promise against deadly pediatric leukemia

Research provides the basis for an additional novel immunotherapy for multiple myeloma patients

Research provides the basis for an additional novel immunotherapy for multiple myeloma patients

Scientists discover novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia

Scientists discover novel therapeutic strategy for FLT3-ITD-positive acute myeloid leukemia

New study clears a pharmacologic hurdle in developing molecularly targeted therapies for AML

New study clears a pharmacologic hurdle in developing molecularly targeted therapies for AML

Researchers discover how Rift Valley fever virus enters cells

Researchers discover how Rift Valley fever virus enters cells

Researchers discover potential Achilles heel of pediatric acute myeloid leukemia

Researchers discover potential Achilles heel of pediatric acute myeloid leukemia

Pinning down Pin1: Potential COVID-19 therapy

Pinning down Pin1: Potential COVID-19 therapy

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

Those undergoing treatment for hematological malignancies show reduced immune response to COVID-19 vaccines

AI can help with the diagnosis of B-cell lymphomas and related leukemias

AI can help with the diagnosis of B-cell lymphomas and related leukemias

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute myeloid leukemia

Novel combination therapy approach to keep leukemia at bay

Novel combination therapy approach to keep leukemia at bay

mRNA BNT162b2 vaccine safe in immunocompromised patients

mRNA BNT162b2 vaccine safe in immunocompromised patients

RNF5 protein plays an unusual role in acute myeloid leukemia, study shows

RNF5 protein plays an unusual role in acute myeloid leukemia, study shows

High-dose chemotherapy followed by immunotherapy benefits patients with acute myeloid leukemia

High-dose chemotherapy followed by immunotherapy benefits patients with acute myeloid leukemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.